Silver Oxide Zinc Oxide Topical Formulation Whitening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current silver oxide formulations, particularly silver(II) oxide, are difficult to incorporate into white cosmetic or pharmaceutical products due to their dark color, which can stain skin and clothing, and are not effective in treating chronic wounds, which are a growing healthcare concern.
Innovation Solution
A topical formulation combining silver oxide and zinc oxide, intimately dispersed in a carrier medium, with specific weight ratios and concentrations to achieve a whitening effect and improve spreadability and anti-microbial efficacy, while maintaining stability against ultraviolet light exposure.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If silver(II) oxide is used in topical formulations, then anti-microbial efficacy is improved, but the formulation becomes dark gray or charcoal gray causing staining and poor aesthetic appeal
Solution Approach 1:
The patent combines silver(II) oxide with zinc oxide in a composite formulation. The zinc oxide acts as a whitening agent that counteracts the dark gray color of silver(II) oxide, producing a formulation with improved aesthetic appeal while maintaining anti-microbial efficacy. This composite approach allows both materials to contribute their beneficial properties simultaneously.
2Object-generated harmful factors
If zinc oxide is added to whiten the formulation, then aesthetic appeal is improved, but the anti-microbial efficacy may be reduced
Solution Approach 1:
The patent optimizes the concentration parameters of both zinc oxide and silver(II) oxide to achieve the desired balance. By carefully controlling the amount of each component, the formulation maintains sufficient anti-microbial activity while achieving adequate whitening effect for cosmetic acceptability.
3Ease of operation
If silver oxide particles are made smaller to improve spreadability, then ease of operation is improved, but the particles may aggregate and reduce stability
Solution Approach 1:
The patent uses zinc oxide particles as an intermediary material that prevents aggregation of silver(II) oxide particles. The zinc oxide acts as a spacer or barrier between silver oxide particles, maintaining their dispersion and preventing clumping while still allowing the formulation to spread easily on the skin.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulation effectively whitens, reducing staining and enhancing aesthetic appeal, while maintaining anti-microbial efficacy and improving wound healing rates in chronic wounds.
Implementation Method 1
silver oxide and zinc oxide, intimately dispersed within a carrier medium
Data Source
AI summary
Topical formulations for application to exposed body tissue.